jbrodkin writes "You don't need Ivy League-type cash to get a supercomputer anymore. Organizations with limited financial resources are snatching up IBM supercomputers now that Big Blue has lowered the price of Blue Gene/L. Alabama-Birmingham and other universities that previously couldn't afford such advanced technology are using supercomputers to cure diseases at the protein level and to solve equally challenging problems. IBM dropped the price of the Blue Gene/L to $800K late last year before releasing a more powerful model, Blue Gene/P, last month. Sales of Blue Gene/L have more than doubled since then, bringing supercomputing into more corners of the academic and research worlds."